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Résumé en
anglais
BACKGROUND & AIMS: Large oesophageal varice (LEV) screening is
recommended in cirrhosis. We performed a prospective study to improve non-
invasive LEV screening.
DESIGN: 287 patients with cirrhosis had upper gastrointestinal endoscopy (LEV
reference), oesophageal capsule endoscopy (ECE), liver elastography and blood
marker analyses. CirrhoMeter (cirrhosis blood test), the most accurate non-invasive
LEV test, was segmented for cirrhosis (reference comparator) or LEV. VariScreen, a
sequential and partially minimally invasive diagnostic algorithm, was developed by
multivariate analysis. It uses CirrhoMeter first, then ECE if CirrhoMeter cannot rule
LEV out or in, and finally endoscopy if CirrhoMeter+ECE combination remains
uninformative.
RESULTS: Diagnostic effectiveness rates for LEV were: cirrhosis-segmented
CirrhoMeter: 14.6%, LEV-segmented CirrhoMeter: 34.6%, ECE: 60.6% and
VariScreen: 66.4% (P ≤ .001 for overall or pair comparison). The respective missed
LEV rates were: 2.8%, 5.6%, 8.3% and 5.6% (P = .789). Spared endoscopy rates
were, respectively: 15.6%, 36.0%, 70.6% and 69%, (P < .001 for overall or paired
comparison except ECE vs VariScreen: P = .743). VariScreen spared 38% of ECE
and reduced missed LEV by 87% compared to classical ECE performed in all
patients. Excepting cirrhosis-segmented CirrhoMeter, these spared endoscopy rates
were significantly higher than that of the Baveno VI recommendation (using
platelets and Fibroscan): 18.4% (P < .001). Ascites and Child-Pugh class
independently predicted endoscopy sparing by VariScreen: from 86.0% in
compensated Child Pugh class A to 24.1% in Child-Pugh class C with ascites.
CONCLUSION: VariScreen algorithm significantly reduced the missed LEV rate
with ECE by 87%, ECE use by 38% and endoscopy requirement by 69%, and even
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